About PEXEGRA

PEXEGRA is a medication used to stimulate the production of white blood cells in patients undergoing chemotherapy. It contains the active ingredient PEGFILGRASTIM, a recombinant DNA-derived human granulocyte-macrophage colony-stimulating factor (GM-CSF).

Key Benefits & Uses

Reduces the incidence of febrile neutropenia in patients receiving chemotherapy
Stimulates the production of white blood cells, including neutrophils and macrophages
Helps to prevent infections and reduce the risk of complications in patients undergoing chemotherapy

Active Ingredient & Action

PEGFILGRASTIM works by binding to specific receptors on the surface of bone marrow cells, stimulating the production and release of white blood cells. This helps to increase the number of neutrophils and macrophages in the blood, reducing the risk of infections and complications in patients undergoing chemotherapy.

Important Notes

PEXEGRA should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully. Patients should be monitored regularly for signs of infection or other complications. PEXEGRA may cause side effects such as bone pain, muscle pain, and fatigue. If you experience any of these symptoms, consult your healthcare professional for advice.